Marlieke De Kraker
Dr Marlieke de Kraker is trained as an epidemiologist, and carried out her PhD on the burden of antimicrobial resistance (AMR) in Europe at the University Medical Centre Groningen and Netherlands’ National Institute for Public Health and the Environment. She is currently engaged with the team of Prof Stephan Harbarth at Geneva University Hospitals, where she contributes to different European projects that aim to maintain and improve accessibility to effective antibiotics (COMBACTE [combacte.com], Ecraid [ecraid.eu]), projects focused on the burden of AMR in Africa (MBIRA [lshtm.ac.uk/ research/centres-projects-groups/mbira], and the impact of mono-clonal antibodies and vaccines on AMR burden (PrIMAVeRa [https://www.primavera-amr.eu/]). Her field of interest involves all aspects of AMR, including national and international surveillance, clinical impact, development of novel preventive and treatment strategies, and innovative approaches to improve clinical trial efficiency to reduce the burden of AMR.